中国癌症杂志 ›› 2015, Vol. 25 ›› Issue (11): 865-870.doi: 10.3969/j.issn.1007-3969.2015.11.005

• 特约专家述评及综述 • 上一篇    下一篇

肿瘤出芽计数在预测T1期结直肠癌淋巴结转移中的应用价值

章琼燕,赵胜男,王 磊,黄 丹,翁微微,盛伟琪   

  1. 复旦大学附属肿瘤医院病理科,复旦大学上海医学院肿瘤学系,上海 20032
  • 出版日期:2015-11-30 发布日期:2016-02-01
  • 通信作者: 盛伟琪 E-mail:shengweiqi@163

The clinical significance of tumor budding in predicting lymph node metastasis of T1 colorectal cancer

ZHANG Qiongyan, ZHAO Shengnan, WANG Lei, HUANG Dan, WENG Weiwei, SHENG Weiqi   

  1. Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2015-11-30 Online:2016-02-01
  • Contact: SHENG Weiqi E-mail: shengweiqi@163.com

摘要: 背景与目的:肿瘤出芽是结直肠癌的不良预后因素。本研究使用10个高倍镜视野计数的方法评价肿瘤出芽,并分析其在预测T1期结直肠癌淋巴结转移中的临床应用价值。方法:通过计数307例T1期结直肠癌10个高倍镜视野下肿瘤出芽个数,参比临床病理特征,建立T1期结直肠癌淋巴结转移的风险分析公式,并在14例新病例中对该公式进行验证。结果:多因素分析结果显示,肿瘤分化水平、脉管侵犯和肿瘤出芽个数与T1期结直肠癌淋巴结转移显著相关。统计分析得出的淋巴结转移的风险分析公式为:Z=1.571×(脉管状态:侵犯为1;无侵犯为0)+2.661×(肿瘤分化:高级别为1;低级别为0)+0.024×(肿瘤出芽个数)-3.885,概率=1/1+e-Z。在14例新病例中得到了验证。结论:通过计数10个高倍镜视野下的肿瘤出芽个数,可以精确地评估淋巴结转移风险,从而协助临床作出合理的决策。

关键词: 肿瘤出芽, 淋巴结转移, 结直肠癌, 风险分析公式

Abstract: Background and purpose: Tumor budding is a poor prognostic factor in colorectal cancer. In this study, we studied the tumor budding by counting the actual number in 10 high power fields and evaluated its clinical application in predicting lymph node metastasis of T1 colorectal cancer. Methods: Tissue specimens from 307 patients with histologically confirmed T1 colorectal cancer were enrolled. The clinicopathological characteristics including tumor budding were evaluated for their predictive value in lymph node metastasis. A formula was created to calculate the risk score for prediction of lymph node metastasis which was validated by 14 new cases. Results: In the multivariate analysis, it showed that tumor grade, lymphovascular invasion and the number of tumor budding were significantly associated with lymph node metastasis. The probability of lymph node metastasis was calculated using the following equations: Z=1.571×(lymphovascular state: invasion, 1; no invasion, 0)+2.661×(tumor grade: high grade, 1; low grade, 0)+0.024×(budding counts)−3.885; Probability=1/1+e−Z. The high scores were correlated with the lymph node metastasis in the validations. Conclusion: We can accurately assess the risk of lymph node metastasis by counting the number of tumor budding in 10 high power fields. Therefore tumor budding could potentially assist treatment decision making in T1 colorectal cancer patients with high-risk lymph node metastasis.

Key words: Tumor budding, Lymph node metastasis, Colorectal cancer, Risk score